Streetbeat News

Price Targets

LECO

Stifel analyst Nathan Jones maintains a Hold rating on Lincoln Electric Holdings (LECO) and raises the price target from $239 to $241.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 2:50 pm

JBHT

Stifel analyst J. Bruce Chan maintains a Hold rating on JB Hunt Transport Servs (NASDAQ:JBHT) and lowers the price target from $188 to $173.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 2:49 pm

ITT

Stifel analyst Nathan Jones has maintained a Buy rating on ITT Inc. (NYSE:ITT) and increased the price target from $141 to $150, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 2:47 pm

ITW

Stifel analyst Nathan Jones has maintained a Hold rating on Illinois Tool Works (ITW) and increased the price target from $258 to $259.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 2:45 pm

HXL

Stifel analyst Bert Subin maintains a Buy rating on Hexcel (NYSE:HXL), but lowers the price target from $90 to $86.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 2:43 pm

FLS

Stifel analyst Nathan Jones maintains a Buy rating on Flowserve (NYSE:FLS) and raises the price target from $51 to $53.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 2:42 pm

CW

Stifel analyst Nathan Jones has maintained a Buy rating on Curtiss-Wright (NYSE:CW) and increased the price target from $255 to $272.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 2:40 pm

DHR

HSBC analyst Rajesh Kumar upgrades Danaher (NYSE:DHR) from Hold to Buy and raises the price target from $250 to $280, indicating a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 2:40 pm

CR

Stifel analyst Nathan Jones has maintained a Buy rating on Crane (NYSE:CR) and increased the price target from $135 to $150.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 2:39 pm

CLDX

HC Wainwright & Co. analyst Joseph Pantginis reiterates a Buy rating on Celldex Therapeutics (NASDAQ:CLDX) and maintains an $80 price target.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 2:35 pm